Form 4 for BSX Boston Scientific
Accepted 2024-10-08 00:00:00 ET · period of report 2024-10-07 · accession 0001225208-24-009233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-08 | 2024-10-07 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $21.07 | +116.6K | 293.0K | +66% | +$2.46M |
| D | 2024-10-08 | 2024-10-07 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $85.00 | -132.5K | 160.5K | -45% | -$11.26M |
| DM | 2024-10-08 | 2024-10-07 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | -116.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-07 | M | A | 59,021 | $17.26 | 235,376 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-07 | M | A | 57,618 | $24.98 | 292,994 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-07 | S | D | 132,527 | $85.00 | 160,467 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-10-07 | M | D | 59,021 | $0.00 | 0 | D | $17.26 · — to 2026-02-22 | 59,021 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-10-07 | M | D | 57,618 | $0.00 | 0 | D | $24.98 · — to 2027-03-03 | 57,618 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant. |